Activity Provided By:

The Leukemia & Lymphoma Society and RMEI Medical Education, LLC.

AML 2021: Strategies for Attack Before Diagnosis and After Remission – Module 2

Overview / Abstract:	Target Audience This activity is designed to meet the educational needs of hematologists, oncologists, and other healthcare professionals involved in the diagnosis and treatment of patients with blood cancers. Program Overview This activity provides an overview of important genetic mutations in acute myeloid leukemia and recent therapeutic advances. Learning Objective Upon completion of this activity, participants should be better able to: Identify the impact of minimal residual disease (MRD) analysis and pre-leukemic clones on the treatment of acute leukemia
Expiration	Mar 02, 2023
Discipline(s)	Physician CME
Format	Online
Credits / Hours	1.0 AMA PRA Category 1 Credit(s)™
Accreditation	ACCME
Presenters / Authors / Faculty	Faculty FACULTY_NAME Gail J. Roboz, MD Professor, Medicine Director, Clinical and Translational Leukemia Program Weill Medical College of Cornell University Division of Hematology and Oncology New York-Presbyterian Hospital New York, NY
Sponsors / Supporters / Grant Providers	The Leukemia & Lymphoma Society
Keywords / Search Terms	Relias LLC Relias LLC., FreeCME., Leukemia, Lymphoma Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map